Evidence map›Paper›PMID 37760735›Full record

ArticleAntibiotics (Basel, Switzerland)2023

Polyclonal Multidrug ESBL-Producing

José João Sumbana, Antonella Santona, Nader Abdelmalek, Maura Fiamma, Massimo Deligios, Alice Manjate, Jahit Sacarlal, Salvatore Rubino, Bianca Paglietti

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pathogens (Basel, Switzerland) · 2024
    Pooled it
  2. Exploring AMR and virulence inOne health (Amsterdam, Netherlands) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

José João SumbanaDepartment of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy.ORCID 0000-0003-2938-1890
Antonella SantonaDepartment of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy.
Nader AbdelmalekDepartment of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy.
Maura FiammaClinical-Chemical Analysis and Microbiology Laboratory, San Francesco Hospital, 08100 Nuoro, Italy.
Massimo DeligiosDepartment of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy.ORCID 0000-0002-3924-4753
Alice ManjateDepartment of Microbiology, Faculty of Medicine, Eduardo Mondlane University, Maputo P.O. Box 257, Mozambique.ORCID 0000-0003-2302-7700
Jahit SacarlalDepartment of Microbiology, Faculty of Medicine, Eduardo Mondlane University, Maputo P.O. Box 257, Mozambique.ORCID 0000-0003-1059-217X
Salvatore RubinoDepartment of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy.
Bianca PagliettiDepartment of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy.
University of Sassari · ITEduardo Mondlane University · MZ

Funding

Ministry of Science and Technology, Higher Education and Vocational Technical of Mozambique D0510
6 · The paper itself

Abstract

Globally, antibiotic-resistant

Indexed as

CTX-M-15ESBLhypervirulent K. pneumoniae ST23K. pneumoniaeMozambiquemultidrug resistant

Identifiers

PMID37760735
PMCPMC10525843
OpenAlexW4386715050

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.